Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response Rates

Despite the recent successes and durable responses with immune checkpoint inhibitors (ICI), many cancer patients, including those with melanoma, do not derive long-term benefits from ICI therapies. The lack of predictive biomarkers to stratify patients to targeted treatments has been the driver of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Seyhan, Attila A., Carini, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820306/
https://www.ncbi.nlm.nih.gov/pubmed/36613491
http://dx.doi.org/10.3390/ijms24010041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820306/
https://www.ncbi.nlm.nih.gov/pubmed/36613491
http://dx.doi.org/10.3390/ijms24010041

Ejemplares similares